Intelligence Platform
Patents
Browse 82 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12324837
ROR1-specific antigen binding molecules
granted patentUS 12312357
PRMT5 inhibiting compounds and uses thereof
granted patentUS 12024509
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted patentUS 11807646
4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease
granted patentUS 11753398
Therapeutic compounds
granted patentUS 11208413
Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
granted patentUS 11130746
Therapeutic compounds
granted patentUS 11053213
Pharmaceutical compounds
granted patentUS 10766903
Piperidine derivatives as inhibitors of ubiquitin specific protease 7
granted patentUS 10766902
Wee-1 inhibiting pyrazolopyrimidinone compounds
granted patentUS 10696654
Therapeutic compounds
granted patentUS 10611760
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted patentUS 10577406
FKBP-L polypeptides and uses in angiogenesis-mediated disorders
granted patentUS 10308617
Triazole benzamide derivatives and the compositions and methods of treatment regarding the
granted patentUS 10155936
Parkin ligase activation methods and compositions
granted patentUS 9714244
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors
granted patentUS 9381228
FKBP-L and uses thereof
granted patentUS 9221838
Inhibitors of AKT activity
granted patentUS 9156853
AKT inhibitor compounds for treatment of cancer
granted patentUS 8546376
Pharmaceutical compounds
granted patentUS 8303985
Skin treatment compositions containing copper-pigment complexes
granted patentUS 8303984
Skin treatment compositions containing copper-pigment complexes
granted patentUS 8298555
Color cosmetic compositions for topical anti-aging skin treatment
granted patentUS 7994299
Compositions and methods for increasing bone mineralization
granted